[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337271-105":59,"doc-detail-337271-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","predicting-survival-in-patients-with-neuroendocrine-prostate-cancer-a-seer-based-comprehensive-study","Predicting Survival in Patients with Neuroendocrine Prostate Cancer - A SEER-Based Comprehensive Study","","Neuroendocrine prostate cancer (NEPC) is an aggressive subtype with poor prognosis and limited reliable tools for individualized outcome prediction. Using Surveillance, Epidemiology, and End Results (SEER) data from 2010–2020, a study of 393 NEPC patients built and validated two Cox-regression–based nomograms to estimate 1-, 3-, and 5-year overall survival (OS) and cancer-specific survival (CSS). Performance was assessed via C-indices, ROC, calibration, and decision-curve analyses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/predicting-survival-in-patients-with-neuroendocrine-prostate-cancer-a-seer-based-comprehensive-study/337271/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/predicting-survival-in-patients-with-neuroendocrine-prostate-cancer-a-seer-based-comprehensive-study/337271.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study purpose for neuroendocrine prostate cancer (NEPC)?","Question",{"text":112,"@type":113},"To develop and confirm nomograms that reliably predict 1-, 3-, and 5-year overall survival and cancer-specific survival for patients with NEPC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data source and time period were used in the analysis?",{"text":117,"@type":113},"Patient data diagnosed with NEPC from 2010 to 2020 were collected from the Surveillance, Epidemiology, and End Results (SEER) program.",{"name":119,"@type":110,"acceptedAnswer":120},"How were the nomograms validated and what metrics were reported?",{"text":121,"@type":113},"Two nomograms for OS and CSS were trained and validated using a 2:1 split, and their performance was evaluated using C-indices, ROC curves, calibration plots, and decision curve analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337271,1790452207,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Predicting Survival in Patients with Neuroendocrine Prostate Cancer: A SEER-Based Comprehensive Study  \nTianlong Luo1,*       \n, Jintao Hu1,*  \n, Bisheng Cheng1  \n, Peixian Chen1  \n, Jianhan Fu1  \n, Haitao Zhong1  \n,  \nJinli Han1  \n, Hai Huang1,2,3,4  \n1 Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 2Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, SunYat-Sen University, 3Guangdong Provincial Clinical Research Center for Urological Diseases, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 4Department of Urology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Guangdong, China  \nOriginal Article Prostate cancer  \npISSN: 2287-4208 / eISSN: 2287-4690  \nWorld J Mens Health 2025 Apr 43(2): 415-427  \n[https://doi.org/10.5534/wjmh.240061](https://doi.org/10.5534/wjmh.240061)  \nPurpose: Neuroendocrine prostate cancer (NEPC) represents a particularly aggressive subtype of prostate cancer with a challenging prognosis. The purpose of this investigation is to craft and confirm the reliability of nomograms that can accurately forecast the 1-, 3-, and 5-year overall survival (OS) and cancer-specific survival (CSS) rates for individuals afflicted with NEPC. Materials and Methods: Data pertaining to patients diagnosed with NEPC within the timeframe of 2010 to 2020 was meticulously gathered and examined from the Surveillance, Epidemiology, and End Results Program (SEER) . To predict OS and CSS, we devised and authenticated two distinct nomograms, utilizing predictive variables pinpointed through both univariate and multivariate Cox regression analyses.  \nResults: The study encompassed 393 of NEPC patients, who were systematically divided into training and validation cohorts at a 2:1 ratio. Key prognostic factors were isolated, verified, and integrated into the respective nomograms for OS and CSS. The performance metrics, denoted by C-indices, stood at 0.730, 0.735 for the training set, and 0.784, 0.756 for the validation set. The precision and clinical relevance of the nomograms were further corroborated by the analysis of receiver operating characteristic curves, calibration plots, and decision curve analyses.  \nConclusions: The constructed nomograms have demonstrated impressive efficacy in forecasting the 1-, 3-, and 5-year OS and rates for patients with NEPC. Implementing these predictive tools in clinical settings is anticipated to considerably enhance the care and treatment planning for individuals diagnosed with this aggressive form of prostate cancer, thus providing tailored and more precise prognostic assessments.  \nKeywords: Observation; Prognosis; Prostatic neoplasms; SEER program; Survival  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0)](http://creativecommons.org/licenses/by-nc/4.0))[ ](http://creativecommons.org/licenses/by-nc/4.0))[which permits unrestricted non-commercial use](which permits unrestricted non-commercial use), distribution, and reproduction in any medium, provided the original work is properly cited.  \nReceived: Mar 7, 2024 Revised: Apr 20, 2024 Accepted: May 20, 2024 Published online Jul 31, 2024  \nCorrespondence to: Jinli Han  [https://orcid.org/0000-0002-7645-5875](https://orcid.org/0000-0002-7645-5875)  \nDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 33 Yingfeng Road, Haizhu District, Guangzhou 510120, China. Tel: +86-137-6086-9855, Fax: +86-20-81871853, E-mail: [hanjinli@mail.sysu.edu.cn](hanjinli@mail.sysu.edu.cn)  \nCorrespondence to: Hai Huang  [https://orcid.org/0000-0002-2013-073X](https://orcid.org/0000-0002-2013-073X)  \nDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 33 Yingfeng Road, Haizhu District, Guangzhou 510120, China. Tel: +86-137-115","cbCait07UMnbyPeM","https://ap.wps.com/l/cbCait07UMnbyPeM","pdf",394058,13,"English","# Introduction\n# Materials and Methods\n# Results\n# Conclusions","[{\"question\":\"What was the study purpose for neuroendocrine prostate cancer (NEPC)?\",\"answer\":\"To develop and confirm nomograms that reliably predict 1-, 3-, and 5-year overall survival and cancer-specific survival for patients with NEPC.\"},{\"question\":\"What data source and time period were used in the analysis?\",\"answer\":\"Patient data diagnosed with NEPC from 2010 to 2020 were collected from the Surveillance, Epidemiology, and End Results (SEER) program.\"},{\"question\":\"How were the nomograms validated and what metrics were reported?\",\"answer\":\"Two nomograms for OS and CSS were trained and validated using a 2:1 split, and their performance was evaluated using C-indices, ROC curves, calibration plots, and decision curve analysis.\"}]","Predicting Survival in Patients with Neuroendocrine Prostate Cancer - A SEER-Based Comprehensive Study | PDF",1790018448,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81aa8447e17e3a001a6f4ec0fb210280.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84db79a94f63b61cf689c6b472e64657.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/796071638a0337484a192cd14e4eeafb.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e83cc296479640acb882a7e0c39e3d2.webp",980,1306]